Concepedia

Author

Lianjun Xing

Longhua Hospital Shanghai University of Traditional Chinese MedicineORCID

Also Known As

L. Xing, LIAN-JUN XING, Lian-Jun Xing, Lian-jun Xing, LianJun Xing, Lianjun Xing

42

Publications

430

Citations

12

H-Index

15

Concepts

All Affiliations

Longhua Hospital Shanghai University of Traditional Chinese MedicineShanghai University of Traditional Chinese MedicineShanghai Municipal Education Commission
LX

About

Lianjun Xing is an author at Longhua Hospital Shanghai University of Traditional Chinese Medicine specializing in oxidative stress, metabolic syndrome, and liver physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

3

3

171

2

Medicine

3

3

171

3

Biochemistry

3

3

171

4

Metabolism

3

3

171

5

Diabetes

1

1

88

Lianjun Xing

×

9

Publications

294

Citations

9

H-Index

YearCitations

Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver

Lianjun Xing, Li Zhang, Tao Liu,

European Journal of Pharmacology

2011

88

Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway.

Zhongping Li, Jiaoya Xu, Peiyong Zheng,

PubMed

2015

44

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease

Tao Liu, Lili Yang, Lu Zou,

Evidence-based Complementary and Alternative Medicine

2013

39

Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway

Tao Wu, Junming Chen, Tiegang Xiao,

World Journal of Gastroenterology

2016

30

Circ_0004913 Inhibits Cell Growth, Metastasis, and Glycolysis by Absorbing miR-184 to Regulate <i>HAMP</i> in Hepatocellular Carcinoma

Mingyuan Wu, Tanlezi Sun, Lianjun Xing

Cancer Biotherapy and Radiopharmaceuticals

2020

26

Baicalin and puerarin reverse epithelial‑mesenchymal transition via the TGF‑β1/Smad3 pathway in�vitro

Tao Wu, Tao Liu, Lianjun Xing,

Experimental and Therapeutic Medicine

2018

24

Inhibition of LXR<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi mathvariant="bold-italic">α</mml:mi></mml:mrow></mml:math>/SREBP-1c-Mediated Hepatic Steatosis by<i>Jiang-Zhi</i>Granule

Miao Wang, Shanshan Sun, Tao Wu,

Evidence-based Complementary and Alternative Medicine

2013

16

Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease

Nan Shen, Yufan Qian, Jielu Pan,

Annals of Translational Medicine

2023

15

Chinese medicinal formula, Qinggan Huoxue Recipe protects rats from alcoholic liver disease via the lipopolysaccharide-Kupffer cell signal conduction pathway

Tao Wu, Tao Liu, Li Zhang,

Experimental and Therapeutic Medicine

2014

12

Page 1